Healthtech Investors & VC Firms in Amsterdam
18 firms in this list, with a median first check of $10.8M. 6 of them lead rounds. Generated from verified public data and updated continuously.
NPM Capital N.V.
AmsterdamGrowth$32M – $320M
65 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Innovation Industries
AmsterdamSeed–Late Stage$2.2M – $54M
25 people
Holland Capital
AmsterdamGrowth–Late Stage
43 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
Rubio Impact Ventures
AmsterdamSeed–Growth
29 people
Forbion
NaardenPre-Seed–Late Stage
24 people
Inkef
AmsterdamSeed–Growth
14 people
4impact capital
The HagueSeed–Series A
8 people
Tablomonto
AmsterdamSeed–Series B
11 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Curie Capital
AmsterdamSeed–Series A
8 people
Avedon Capital Partners
AmsterdamGrowth–Late Stage
2 people
Rocket Capital
AmsterdamSeries B–Late Stage
9 people
Schouten Investments
AmsterdamSeries B–Late Stage
2 people
Clear.bio
Amsterdam
Philips Ventures
AmsterdamSeed–Growth
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Healthtech Seed Investors & VC Firms (2488)
Data sourced from public filings and firms' own websites — see our methodology.

















































